Reiterate BUY with revised TP of Rs 592 (32x Dec-20E EPS) vs. 40x for UNSP.RDCK trades at relatively cheap valuation at 25/22x FY20/21E EPS vs. 47/37x for UNSP. Radico Khaitan (RDCK) delivered healthy performance in 3QFY19. Revenue/EBITDA/PAT grew by 14.6/27/51% YoY. For 9MFY19, revenue/EBITDA/PAT grew at 18/37/69%.